DIRS.INFO The most relevant business & tech news

Goldman Sachs lowered its rating on Estée Lauder to neutral, and its new price target calls for a slight decline going forward. Elsewhere, Daiwa raised its price target on Nvidia, which points to more than 10% upside over the next 12 months. The firm stood by its outperform rating on the chipmaker stock, but lifted its price target to $900 from $535. FLYW YTD mountain FLYW in 2024 Faucette accompanied his downgrade by lifting his price target to $30 from $27. He also lifted his price target on the stock to $40 from $30, implying upside of 24.6% from Thursday's close.

Persons: Goldman Sachs, Estée Lauder, Jefferies, Root, Daiwa, Brad Sills, Sills, — Lisa Kailai Han, Stephens, Vita Coco, Coco, Jim Salera, COCO, Lisa Gill, Gill, Louis Miscioscia, Miscioscia, Lisa Kailai Han, Piper Sandler downgrades, Piper Sandler, Mark Fitzgibbon, Fitzgibbon, Morgan Stanley downgrades Flywire, Morgan Stanley, James Faucette, Faucette, Goldman Sachs downgrades Estée Lauder, Lauder, Goldman, Yaron Kinar, Kinar, Fred Imbert Organizations: CNBC, Nvidia, Bank of America, of America, Vertex, Accenture, RSM, BDO, JPMorgan, Daiwa, Markets, Riding, AMD, Intel, York Community Bancorp, York Community, New York Community Bancorp, Travel, B2B, U.S, Jefferies Locations: York, Canada, Asia, China, Hainan, Thursday's

☆ Buy these top tech stocks before it's too late, Morgan Stanley says
▼ + stars: | 2024-02-03 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

Palo Alto Networks Analyst Hamza Fodderwala said the firm's recent security checks show cyber threats remain a top priority for IT. That bodes well for Palo Alto in 2024 and beyond, according to Fodderwala. Further, Palo Alto is better positioned for AI than investors believe, Fodderwala added. Palo Alto is scheduled to report earnings in late February. But investor skepticism remains leaving Hettenbach to pound the table for RCM shares.

Persons: Morgan Stanley, James Faucette, Faucette, Hamza Fodderwala, Fodderwala, Craig Hettenbach, Hettenbach, Docebo Organizations: CNBC, Palo Alto Locations: Palo Alto, Docebo, Tenable, Palo, Hettenbach

☆ More people need transplants than there are organ donors. Pigs might offer a solution
▼ + stars: | 2024-01-30 | by ( Jen Christensen | ) edition.cnn.com time to read: +23 min

The need for more transplant organs is immense and growing. Researchers have transplanted genetically modified pig kidneys and hearts into people who were brain-dead to test whether they work in humans. Although Larry Faucette was too sick for a human heart transplant, University of Maryland doctors said he seemed physically strong enough for a genetically modified pig heart. It was more than a decade after the first heart transplant but long before such procedures became relatively routine. “We learned that the pig heart is an adequate substitute for a human heart.

Persons: Lawrence Faucette, Ann, he’d, ” Ann, Larry Faucette, Ann Faucette Ann, Larry, didn’t, ”, Robert Montgomery, “, Shelby Lum, ” Montgomery, Xenotransplantation, Art Caplan, Caplan, Babe ”, ” Caplan, They’re, eGenesis, people’s, Dr, Mike Curtis, Sanjay Gupta, ” Curtis, hasn’t, Julie O’Hara, Jim Parsons, Jayme Locke, couldn’t, Locke, Parsons, NYU —, Montgomery —, O’Hara, ” Locke, David Bennett Sr, Mary, David Jr, Bartley Griffith, Bennett, they’ve, Muhammad M, Mohiuddin, Larry Faucette’s, David Bennett’s, ” Griffith, xenotransplantation Ann Faucette, Wilbur, White’s, Ann Faucette, NYU ethicist Caplan, they’re, NYU’s Montgomery, UAB’s Locke, Steve Wood, ’ Curtis, “ I’m, it’s, ” O’Hara, Bennett’s, Larry Faucette —, ” Bennett’s, Faucette, who’d, Griffith, would’ve, Kate, Lucy, Nadia Kounang Organizations: CNN, Food and Drug Administration, University of Maryland, FDA, National Institute of Allergy, NYU Langone Transplant Institute, NYU Langone's Transplant, NYU Grossman School, Medicine’s Department of Population Health, “ Disney, University of Alabama, Transplant Institute, Parsons Family, Birmingham, NYU, University of Maryland School of Medicine, Doctors, University of Maryland Medical Center, Uno, UAB, CNN Health, NFL Locations: Frederick , Maryland, United States, Montgomery, “, Midwest, Yucatan, Maryland

☆ Second person to receive experimental pig heart transplant dies nearly six weeks after procedure
▼ + stars: | 2023-10-31 | by ( Nadia Kounang | ) edition.cnn.com time to read: +3 min

CNN —Lawrence Faucette, the second living person to receive a genetically modified pig heart in a transplant, has died six weeks after the experimental procedure. Griffith had performed the experimental surgery. Faucette, 58, was first admitted to UMMC on September 14 after experiencing symptoms of heart failure and underwent the experimental transplant six days later. His heart disease and pre-existing conditions made him ineligible for a traditional human heart transplant. In January 2022, the University of Maryland also performed the first such experimental surgery on 57-year-old David Bennett, who died two months following the surgery.

Persons: CNN — Lawrence Faucette, “ Mr, Faucette’s, Dr, Bartley Griffith, Griffith, UMMC, “, ” Faucette, ”, Ann Faucette, “ We’ve, ” Griffith, Doctors, Ann, “ Larry, Sanjay Gupta, David Bennett, Bennett Organizations: CNN, University of Maryland Medical Center, University of Maryland School of Medicine, CNN Health, University of Maryland Locations: UMMC

WASHINGTON (AP) — The second person to receive a transplanted heart from a pig has died, nearly six weeks after the highly experimental surgery, his Maryland doctors announced Tuesday. Lawrence Faucette, 58, was dying from heart failure and ineligible for a traditional heart transplant when he received the genetically modified pig heart on Sept. 20. According to the University of Maryland School of Medicine, the heart had seemed healthy for the first month but began showing signs of rejection in recent days. The Maryland team last year performed the world’s first transplant of a heart from a genetically altered pig into another dying man. David Bennett survived two months before that heart failed, for reasons that aren’t completely clear although signs of a pig virus later were found inside the organ.

Persons: Lawrence Faucette, Faucette, Faucette’s, Ann, “, David Bennett, Faucette's, ” Dr, Bartley Griffith, — Organizations: WASHINGTON, University of Maryland School of Medicine, Maryland, Navy, Food and Drug Administration, Associated Press Health, Science Department, Howard Hughes Medical Institute’s Science, Educational Media Group, AP Locations: Maryland, Frederick , Maryland

☆ Second Maryland Man to Receive an Altered Pig’s Heart Has Died
▼ + stars: | 2023-10-31 | by ( Roni Caryn Rabin | ) www.nytimes.com time to read: +1 min

A 58-year-old man with heart failure who received a new heart from a genetically modified pig died on Monday, nearly six weeks after receiving the pig organ, University of Maryland Medical Center officials announced on Tuesday. The first patient, 57-year-old David Bennett, died last year, two months after his transplant. He had developed multiple complications, and traces of a virus that infects pigs were found in his new heart. Both of the patients had terminal heart disease when they received the transplanted organs, and neither managed to recover sufficiently to leave the hospital. But while doctors said that Mr. Bennett did not show any signs of acute rejection of the new heart, which is the most significant risk in organ transplants, they said that Mr. Faucette’s transplanted heart had started to display some initial signs of rejection.

Persons: Lawrence Faucette, David Bennett, Mr, Bennett, Faucette’s Organizations: University of Maryland Medical Center Locations: Frederick, Md

☆ Doctor's transplanted a genetically-engineered pig heart into a human, again, and now the saved patient has reached a major milestone
▼ + stars: | 2023-10-20 | by ( Lauran Neergaard | Associated Press | ) www.businessinsider.com time to read: +3 min

The pig heart transplant patient lived to celebrate the one-month anniversary of his surgery. The first pig heart transplant patient died two months after surgery due to heart failure. The first pig heart transplant patient, David Bennett, died two months after surgery. In Friday's hospital video, Faucette's doctors said the pig heart has shown no sign of rejection. Tom Jemski/University of Maryland School of Medicine via APMany scientists hope xenotransplants one day could compensate for the huge shortage of human organ donations.

Persons: —, — It's, he's, Lawrence Faucette, Faucette, Chris Wells, David Bennett, Mark Teske, Muhammad Mohiuddin, Lawrence Faucette's, Tom Jemski Organizations: Service, University of Maryland School of Medicine, Maryland, AP, Food and Drug Administration, Associated Press Health, Science Department, Howard Hughes Medical Institute's Science, Educational Media Group Locations: WASHINGTON, Maryland

Lawrence Faucette was dying from heart failure and ineligible for a traditional heart transplant when doctors at the University of Maryland School of Medicine offered the highly experimental surgery. In the first glimpse of Faucette provided since the Sept. 20 transplant, hospital video shows physical therapist Chris Wells urging him to push through a pedaling exercise to regain his strength. The Maryland team last year performed the world’s first transplant of a heart from a genetically altered pig into another dying man. David Bennett survived just two months before that heart failed, for reasons that aren’t completely clear although signs of a pig virus later were found inside the organ. In Friday’s hospital video, Faucette’s doctors said the pig heart has shown no sign of rejection.

Persons: — It’s, he’s, Lawrence Faucette, Faucette, Chris Wells, “ That’s, ” Faucette, David Bennett, —, ”, Muhammad Mohiuddin Organizations: WASHINGTON, University of Maryland School of Medicine, Maryland, Food and Drug Administration, Associated Press Health, Science Department, Howard Hughes Medical Institute’s Science, Educational Media Group, AP Locations: Maryland

Two days later, the man was cracking jokes and able to sit in a chair, Maryland doctors said Friday. “You know, I just keep shaking my head – how am I talking to someone who has a pig heart?” Dr. Bartley Griffith, who performed the transplant, told The Associated Press. “It’s just an amazing feeling to see this pig heart work in a human,” said Dr. Muhammad Mohiuddin, the Maryland team’s xenotransplantation expert. That FDA allowed this second case “suggests that the agency is not ready to permit a pig heart clinical trial to start,” Mashke added. The pig heart, provided by Blacksburg, Virginia-based Revivicor, has 10 genetic modifications – knocking out some pig genes and adding some human ones to make it more acceptable to the human immune system.

Persons: –, “, ” Lawrence Faucette, Dr, Bartley Griffith, David Bennett, Ann Faucette, ”, Faucette, “ It’s, Muhammad Mohiuddin, Karen Maschke, ” Mashke Organizations: WASHINGTON, — Surgeons, Navy, University of Maryland Medicine, Associated Press, Maryland, Food and Drug Administration, FDA, National Institutes of Health, Maryland team’s, Hastings Center, Associated Press Health, Science Department, Howard Hughes Medical Institute’s Department of Science Education, AP Locations: Maryland, Frederick , Maryland, U.S, Blacksburg , Virginia

☆ AI lending firm Upstart jumps as $2 bln funding news squeezes bears
▼ + stars: | 2023-05-10 | by ( ) www.reuters.com time to read: +2 min

May 10 (Reuters) - Shares of highly shorted Upstart Holdings (UPST.O) jumped 32% in premarket trading on Wednesday, squeezing out bearish investors, after the artificial intelligence-driven lending marketplace secured an additional $2 billion in funding. "(The) committed funding agreements are a concrete step towards stabilizing Upstart's business," said James Faucette, analyst at Morgan Stanley, raising its price target on the stock to $13 from $10. At current levels, short sellers stand to lose about $122 million, according to analytics firm Ortex. When there is a rush of demand from short sellers looking to exit bearish bets due to a rise in a stock's price, it pushes prices even higher, resulting in a short squeeze. The company's net loss per share, excluding items, was 47 cents, beating analysts' estimates of 81 cents loss per share, according to Refinitiv.

☆ AI lending firm Upstart jumps as $2 bln funding squeezes bears
▼ + stars: | 2023-05-10 | by ( Medha Singh | ) www.reuters.com time to read: +2 min

May 10 (Reuters) - Shares of highly shorted Upstart Holdings (UPST.O) jumped 32% in early trading on Wednesday, squeezing out bearish investors, after the artificial intelligence-driven lending marketplace secured an additional $2 billion in funding. "(The) committed funding agreements are a concrete step towards stabilizing Upstart's business," said James Faucette, analyst at Morgan Stanley, raising its price target on the stock to $13 from $10. At current levels, short sellers stand to lose about $122 million, according to analytics firm Ortex. "With the price in Upstart jumping up over 30%, some short sellers will try to close their positions... adding additional buy pressure on the stock," said Peter Hillerberg, co-founder of Ortex. The company's net loss per share, excluding items, was 47 cents, beating analysts' estimates of 81 cents loss per share, according to Refinitiv.

☆ Morgan Stanley says this payments stock could struggle without Block deal finalized
▼ + stars: | 2023-04-03 | by ( Alex Harring | ) www.cnbc.com time to read: +2 min

Marqeta will have a difficult year ahead without an ironed out renewal agreement with Block , according to Morgan Stanley. Analyst James Faucette downgraded the payment services stock to equal weight from overweight and cut his price target to $4.50 from $8. Faucette's new target implies the stock will shed 1.5% over the next year after previously being expected to jump 75.1%. Faucette said the company has yet to finalize a deal renewal with Block. Though a renewal seems likely, Faucette said it's hard to predict the details given the fact that Block should have power to bargain aggressively.

☆ Younger consumers are driving investor interest in Block, says Morgan Stanley's James Faucette
▼ + stars: | 2023-03-28 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailYounger consumers are driving investor interest in Block, says Morgan Stanley's James FaucetteJames Faucette, research analyst at Morgan Stanley, joins 'The Exchange' to discuss the durability of revenue streams in payment names, the emerging crypto payment stock to watch, and opportunities for digital wallet investments.

☆ Morgan Stanley says this fintech stock is due for a rebound after back-to-back years of losses
▼ + stars: | 2023-02-14 | by ( Alex Harring | ) www.cnbc.com time to read: +2 min

Fidelity National Information Services could be in for a big jump going forward, according to Morgan Stanley. Analyst James Faucette upgraded the fintech stock to overweight from equal weight and upped his price target by $6 to $79. Fidelity National Information Services advanced nearly 2% in premarket trading on Tuesday. Faucette said the market has priced in "too draconian" of a multiple for the merchant business in recent years. The move comes as venture capital investment falls across the board, which Faucette thinks could help Fidelity National Information Services.

☆ Stocks making the biggest moves premarket: Palantir, Coca-Cola, Marriott and more
▼ + stars: | 2023-02-14 | by ( Jesse Pound | ) www.cnbc.com time to read: +4 min

Here are the stocks making notable moves before the opening bell on Tuesday, Feb. 14. Palantir — Shares of the software company surged 18% in extended trading after Palantir reported it made a profit in the fourth quarter, the first GAAP profit in the company's history. Marriott — The hotel stock rose nearly 2% in premarket trading after Marriott beat estimates on the top and bottom lines for the fourth quarter. Cadence Design Systems — The electronics design stock rose 5% premarket after Cadence beat estimates on the top and bottom lines for the fourth quarter, according to StreetAccount. Amkor Technology — The semiconductor stock fell about 3% premarket after Amkor's fourth quarter earnings per share came in at 67 cents, three cents below estimates, according to StreetAccount.

☆ Morgan Stanley downgrades Affirm, says the payment firm's offerings are too narrow for its ambitions
▼ + stars: | 2023-02-10 | by ( Sarah Min | ) www.cnbc.com time to read: +2 min

It's time to step to the sidelines on Affirm following its disappointing earnings results this week, according to Morgan Stanley. Analyst James Faucette downgraded the online payments stock to equal weight from overweight, saying the scope of Affirm's offerings are too narrow. Affirm shares fell more than 3% in the premarket Friday. What's more, Affirm missed analyst expectations on both the top and bottom lines in its second-quarter earnings report. Affirm shares have increasingly come under pressure since the company's initial public offering in January 2021.

Not everyone who has a pet can deduct their pet care costs, but it's worth learning the rules. Here are five unusual tax deductions that accountants say many people don't even know they might be eligible to take. See Insider's picks for the best tax software »Insider's Featured Tax Software Tax SlayerLiberty TaxH&R Block Tax Software Chevron icon It indicates an expandable section or menu, or sometimes previous / next navigation options. Editor's Rating 4.6/5 A five pointed star A five pointed star A five pointed star A five pointed star A five pointed star Editor's Rating 3.7/5 A five pointed star A five pointed star A five pointed star A five pointed star A five pointed star Editor's Rating 4.5/5 A five pointed star A five pointed star A five pointed star A five pointed star A five pointed star Learn more On Tax Slayer's website Learn more On Liberty Tax's website Learn more On H&R Block's website1. However, she does share that in order to take these deductions, you have to itemize — you can deduct expenses that exceed 7.5% of your adjusted gross income.

When I looked at how much we were spending on my dad, I wondered if I could list him as a dependent. Tax dependents are more than just childrenFirst, a little tax 101: A dependent is a qualified person whose living expenses you pay for. You can "claim" dependents on your taxes, which lower the amount of taxes you have to pay. "Generally, parents who live in a nursing home cannot be claimed as dependents," Gallagher told me. I won't be claiming my dad on my taxes, but I will be paying more attention to how much I spend on him.

☆ This payment stock can surge 25% as a potential recession means less competition, Morgan Stanley says
▼ + stars: | 2023-01-17 | by ( Carmen Reinicke | ) www.cnbc.com time to read: +2 min

Shares of Global Payments are set to surge as competition falls to the wayside, according to Morgan Stanley. Less competition good for shares The changing competitive landscape should favor incumbents such as Global Payments, according to Faucette. In addition, Global Payments is top of the list in the category due to its strategic outlook, including a focus on mergers and acquisitions. Merchant exposure Global Payments also has high merchant exposure, which might not be as much of a detriment in a recession as feared, according to the note. "With this type of backdrop, we would expect GPN Merchant revenue growth to remain solidly mid- to high single digits."

Search resuls for: "Faucette"

19 mentions found